Insights

Recent articles, reports, and other media from Velocity

Raghu Punnamraju, Velocity CTO, On AI in Clinical Research

May 30, 2024

Velocity is using multimodal LLMs, like OpenAI’s GPT-4o and others, to enhance productivity. At the forefront of this shift is Raghu Punnamraju, Velocity’s Chief Technology Officer. In this article he shares his thoughts on the rapid evolution of LLMs, and how quickly new tools are being applied to improve quality and efficiency. We have been anticipating … Read more

Video: Velocity Site Tour

May 23, 2024

Enjoy a virtual tour of Velocity’s Durham, NC site, which showcases many of the features and standard equipment present at Velocity sites worldwide. Standard Velocity site features: Private exam rooms Comfortable patient reception areas Facilities for extended-stay PK studies Ample parking Secure monitoring rooms and workstations equipped with phones and high-speed internet Individual and secure … Read more

Video: Vaccine CARE Council Leader Mark Turner, MD

May 21, 2024

“Next to clean water, vaccines are probably responsible for more saved lives than anything else we’ve done in medicine.” -Mark Turner, MD, Vaccine CARE Council Leader and Velocity Principal Investigator in Boise, ID. Given the constant evolution of viruses and the massive medical and economic burdens imposed by viral diseases, vaccine research remains a global … Read more

Video: CNS CARE Council Leader Beth Safirstein, MD

May 15, 2024

Beth Safirstein, MD, leads a site that was recently recognized by a top 10 pharma Sponsor as a leading U.S. enroller of diverse patients. As the chair of the CNS CARE Council, Dr. Safirstein is one of the expert Principal Investigators who will inform the way Velocity sites shape and share best practices to reach … Read more

Video: MASH CARE Council Leader Nadege Gunn, MD, CPI

May 6, 2024

“Clinical research is really the only opportunity we have to give our patients some hope and some perspective that their disease will one day be treatable.” Nadege Gunn, MD, CPI, has consistently championed community engagement and physician referrals to drive successful clinical trial enrollment at her site in Waco, TX. As a MASH CARE Council … Read more

Six Proven Ways to Strengthen Community Ties

April 29, 2024

Velocity recently asked some key employees to come together and discuss a wide array of issues impacting diversity, equity, and inclusion (DEI) in trials. Velocity’s ongoing goals are to share best practices, identify and address shortcomings, and bring as many perspectives and viewpoints to the table as possible to advance clinical trials and deliver vital … Read more

Article: Blazing a Trail in Clinical Research

April 29, 2024

To celebrate the upcoming Clinical Trials Day and the ‘Trailblazers Among Us’ theme, Paul Evans, President and CEO of Velocity, and Victoria DiBiaso, Head, Patient Informed Development & Health Value Translation at Sanofi, have coauthored this article. In the post, they review several of the opportunities and challenges inherent in shaping a better future for … Read more

Video: Cardiometabolic CARE Council Leader Shishir Khetan, MD

April 24, 2024

Shishir Khetan, MD, is a Principal Investigator and Senior Medical Director at Velocity. He’s also a leading expert for the Cardiometabolic CARE Council. But as he explains in this video, he’s excited about the opportunities the CARE Council model is creating for investigators. Through expert knowledge exchange — including mentoring and training opportunities provided by … Read more

Video: Cardiometabolic CARE Council Leader William Cromwell, MD, FAHA, FNLA

April 18, 2024

Heart disease remains the leading cause of death worldwide. The proliferation of heart issues — paired with lifestyle factors that complicate patient recruitment and study design — reflect an urgent need for expert-led clinical trials. Moreover, intersections among heart health and metabolic research offer promising opportunities to confront diseases affecting a growing, aging population, and … Read more

Video: MASH CARE Council Leader Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG

April 10, 2024

The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rising. In light of the stark unmet needs in liver disease treatment — particularly for metabolic dysfunction-associated steatohepatitis (MASH) — there’s a pressing need for more sites equipped to effectively support advanced liver disease research. As Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG, mentions … Read more

Learn more about Velocity's capabilities

Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.

Join a remarkable team doing remarkable work

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.

Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Quality. Continuity. Velocity.